Date published: 2026-6-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

v-SNARE Ykt6p Inhibitors

v-SNARE Ykt6p inhibitors belong to a specific chemical class that plays a pivotal role in regulating intracellular vesicle trafficking within eukaryotic cells. These inhibitors are designed to target the Ykt6p protein, which is a member of the vesicle soluble N-ethylmaleimide-sensitive factor attachment protein receptor (v-SNARE) family. The v-SNAREs, including Ykt6p, are crucial components of the cell's secretory and endocytic pathways, responsible for ensuring the precise fusion of transport vesicles with their target membranes. Inhibition of Ykt6p function disrupts these fusion events, resulting in significant alterations to intracellular trafficking and vesicle transport.

v-SNARE Ykt6p inhibitors typically consists of small molecules designed to specifically bind to and inhibit the activity of the Ykt6p protein. These inhibitors work by disrupting the formation of the SNARE complex, a critical step in vesicle fusion. By preventing the Ykt6p protein from participating in the SNARE complex assembly, these inhibitors hinder the fusion of vesicles with their target membranes, thereby impacting processes such as exocytosis, endocytosis, and membrane recycling. This disruption in intracellular trafficking can have profound effects on various cellular functions, including protein secretion, membrane recycling, and organelle maintenance.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hydroxylamine solution

7803-49-8sc-250136
100 ml
$72.00
(0)

Interferes with the formation of SNARE complexes by modifying cysteine residues on Ykt6p, affecting its ability to mediate vesicle fusion.

N-Ethylmaleimide

128-53-0sc-202719A
sc-202719
sc-202719B
sc-202719C
sc-202719D
1 g
5 g
25 g
100 g
250 g
$22.00
$69.00
$214.00
$796.00
$1918.00
19
(1)

Alkylates thiol groups on cysteine residues within Ykt6p, preventing SNARE complex formation.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Inhibits dynamin, indirectly affecting vesicle scission and potentially reducing the availability of vesicles for Ykt6p to act upon.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi structure, indirectly affecting the trafficking pathways that Ykt6p is involved in.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Disrupts Golgi pH gradient, indirectly affecting the trafficking pathways that Ykt6p is involved in.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Destabilizes microtubules, indirectly affecting vesicle transport that Ykt6p mediates.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Inhibits actin polymerization, indirectly affecting cytoskeletal dynamics involved in vesicle movement where Ykt6p operates.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Binds tubulin, preventing microtubule polymerization, indirectly affecting vesicle transport that Ykt6p mediates.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$102.00
$235.00
$459.00
$1749.00
$2958.00
4
(0)

Binds tubulin, disrupting microtubule assembly, indirectly affecting vesicle transport that Ykt6p mediates.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Affects inositol monophosphatase and disrupts phosphoinositide signaling, indirectly affecting membrane trafficking and vesicle fusion where Ykt6p is involved.